Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Editas Medicine Inc’s stock clocked out at $2.25, up 7.14% from its previous closing price of $2.1. In other words, the price has increased by $7.14% from its previous closing price. On the day, 3.01 million shares were traded. EDIT stock price reached its highest trading level at $2.31 during the session, while it also had its lowest trading level at $2.15.
Ratios:
To gain a deeper understanding of EDIT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.08 and its Current Ratio is at 3.08. In the meantime, Its Debt-to-Equity ratio is 0.50 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 28, 2025, initiated with a Buy rating and assigned the stock a target price of $3.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when Parison Amy sold 446 shares for $1.72 per share. The transaction valued at 769 led to the insider holds 17,506 shares of the business.
Burkly Linda sold 726 shares of EDIT for $1,252 on Jun 03 ’25. The EVP, CHIEF SCIENTIFIC OFFICER now owns 69,519 shares after completing the transaction at $1.72 per share. On Jun 03 ’25, another insider, O’Neill Gilmore Neil, who serves as the CEO of the company, sold 15,192 shares for $1.72 each. As a result, the insider received 26,196 and left with 280,282 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 188354016 and an Enterprise Value of -1477067. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.26 while its Price-to-Book (P/B) ratio in mrq is 3.02. Its current Enterprise Value per Revenue stands at -0.041 whereas that against EBITDA is 0.007.
Stock Price History:
The Beta on a monthly basis for EDIT is 2.11, which has changed by -0.53222454 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $6.05, while it has fallen to a 52-week low of $0.91. The 50-Day Moving Average of the stock is 34.02%, while the 200-Day Moving Average is calculated to be 9.75%.
Shares Statistics:
It appears that EDIT traded 2.08M shares on average per day over the past three months and 3090070 shares per day over the past ten days. A total of 83.71M shares are outstanding, with a floating share count of 82.95M. Insiders hold about 0.91% of the company’s shares, while institutions hold 54.29% stake in the company. Shares short for EDIT as of 1748563200 were 8997908 with a Short Ratio of 4.32, compared to 1745971200 on 11609743. Therefore, it implies a Short% of Shares Outstanding of 8997908 and a Short% of Float of 10.780000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
